Remestemcel-L company forecast PDUFA is / was as far as we know still over the next 6 months. We were anticipating Dec 22 BLA lodgement, which looks like it has not materialised. So what could be occurring?
As @reg suggested, the company is most likely either waiting for FDA comment on the additions to the IND file, or there is a possibility they received something unfavourable back, and are acting prior to submission.
One analyst group was stating Q4 22 that BLA would be Jan 23, so there is also a chance this was the plan all along...although if it were, if PDUFA was 6 months the approval would be Q3 23 and not H1
-
- There are more pages in this discussion • 2,984 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
0.028(1.70%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.67 | $1.61 | $3.543M | 2.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 36201 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 30635 | 21 |
View Market Depth
| Last trade - 11.49am 04/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |